Nurse Practitioner Program year 2024 Reported 2021–2024 Source: CMS Open Payments, 2026 publication

Eric Yoerin

Nurse Practitioner Milwaukee, WI Nurse Practitioner

NPI 1912333253 CMS profile 10714156

2801 W Kinnickinnic River Pkwy, Suite 345, Milwaukee, WI 53215

Open in the dashboard

General payments

$5,568

50 records reported · program years 2021–2024

Research payments

$0

Paid to them · None reported · program years 2021–2024

Ownership & investment interest

$0

None reported

Through program year 2024, Eric Yoerin of Milwaukee, WI is reported in the CMS Open Payments database as having received $5,568 across 50 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 93rd percentile of Nurse Practitioner profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

4 rows
Year Kind Relative to this record's peak year Amount Records
2024 General $3,046 24
2023 General $239 4
2022 General $1,896 16
2021 General $387 6

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Eric Yoerin
  • Nurse Practitioner median
  • Middle half of Nurse Practitioner
  • National median

In program year 2025, general payments to Eric Yoerin were reported at $0. Among 41,044 Nurse Practitioner profiles paid that year, the median was $174 and the middle half received between $55 and $557.

Show as a table
Year Eric Yoerin Nurse Practitioner median Middle half National median
2019 $0 $50 $22–$97 $163
2020 $0 $40 $16–$108 $114
2021 $387 $135 $40–$426 $132
2022 $1,896 $152 $48–$470 $149
2023 $239 $166 $54–$529 $160
2024 $3,046 $173 $55–$556 $164
2025 $0 $174 $55–$557 $169

Breakdown

Who paid General payments · program years 2021–2024
  1. Smith+Nephew, Inc. $5,568 50 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2024
  1. Travel and Lodging $3,660 10 payments
  2. Food and Beverage $1,909 40 payments
Products named General payments · program years 2021–2024
  1. ULTRABUTTON $1,571 8 payments
  2. REAL INTELLIGENCE $1,312 4 payments
  3. BIOSURE $821 9 payments
  4. Mini-Open Latarjet $681 4 payments
  5. Bioinductive Implant with Arthroscopic Delivery System - Medium $638 10 payments
  6. ACUFEX $637 7 payments
  7. FIRSTPASS $474 3 payments
  8. ACUFEX DIRECTOR $474 3 payments
  9. JOURNEY II $401 3 payments
  10. Bone Anchors with Arthroscopic Delivery System $313 4 payments
  11. Other $1,235 21 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 8 drugs

Part D claims

384

Median for Nurse Practitioner: 389

Drug cost

$3,649

Median for Nurse Practitioner: $21,885

Branded share of claims

54.4%

Median for Nurse Practitioner: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 173 $2,058
Doxycycline Hyclate Generic 61 $602
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 36 $327
Diclofenac Sodium Generic 12 $202
Meloxicam Generic 36 $173
Cyclobenzaprine Hcl Generic 35 $135
Methylprednisolone Generic 15 $133
Amoxicillin Generic 16 $18

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 229,976 Part D prescribers listed as Nurse Practitioner; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 25 billing codes

Paid by Medicare

$25,521

Of which drugs: $10,048

Medicare patients

133

Average age 72

Services billed

2,336

90 women, 43 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Depression 42%
Ischemic heart disease 39%
Chronic kidney disease 39%
Diabetes 35%
Heart failure 23%
COPD 22%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Hyaluronan or derivative, synvisc or synvisc-one, for intra-articular injection, 1 mg J7325 Office 16 1,201 $7,729
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 57 588 $400

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

50 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner in Wisconsin

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2024

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record